Confusion reigned this week over the fate of an $850m loan for India’s Tata Chemicals, amid calls from one of the lead banks for the pricing on the deal to be revised.
One bookrunner on the facility said the deal was likely to be repriced, or flexed, higher within the next week to 10 days.
However, another banker said that this was: "Not true. There is no flex talk at this point."
The remaining bookrunners declined to comment or were unavailable